By BY SHARON LAFRANIERE AND NOAH WEILAND from NYT U.S.
https://ift.tt/2ULpeZe
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
F.D.A. Will Attach Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine
By BY SHARON LAFRANIERE AND NOAH WEILAND from NYT U.S.
https://ift.tt/2ULpeZe
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
No comments:
Post a Comment